These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7641907)

  • 1. An estimate of the cost of in vitro fertilization services in the United States in 1995.
    Collins JA; Bustillo M; Visscher RD; Lawrence LD
    Fertil Steril; 1995 Sep; 64(3):538-45. PubMed ID: 7641907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic implications of insurance coverage for in vitro fertilization in the United States. A review.
    Omurtag KR; Styer AK; Session D; Toth TL
    J Reprod Med; 2009; 54(11-12):661-8. PubMed ID: 20120898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tax credits, insurance, and in vitro fertilization in the U.S. military health care system.
    Wu M; Henne M; Propst A
    Mil Med; 2012 Jun; 177(6):745-7. PubMed ID: 22730853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of in vitro fertilization.
    Collins J
    Semin Reprod Med; 2001 Sep; 19(3):279-89. PubMed ID: 11679909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An international survey of the health economics of IVF and ICSI.
    Collins J
    Hum Reprod Update; 2002; 8(3):265-77. PubMed ID: 12078837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost of assisted reproductive technologies for a health maintenance organization.
    Hidlebaugh DA; Thompson IE; Berger MJ
    J Reprod Med; 1997 Sep; 42(9):570-4. PubMed ID: 9336753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health benefits in 2014: stability in premiums and coverage for employer-sponsored plans.
    Claxton G; Rae M; Panchal N; Whitmore H; Damico A; Kenward K
    Health Aff (Millwood); 2014 Oct; 33(10):1851-60. PubMed ID: 25214470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Great Recession, insurance mandates, and the use of in vitro fertilization services in the United States.
    Kiatpongsan S; Huckman RS; Hornstein MD
    Fertil Steril; 2015 Feb; 103(2):448-54. PubMed ID: 25497450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State trends in premiums and deductibles, 2003-2010: the need for action to address rising costs.
    Schoen C; Fryer AK; Collins SR; Radley DC
    Issue Brief (Commonw Fund); 2011 Nov; (26):1-38. PubMed ID: 22097393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost analysis of shared oocyte in vitro fertilization.
    Peskin BD; Austin C; Lisbona H; Goldfarb JM
    Obstet Gynecol; 1996 Sep; 88(3):428-30. PubMed ID: 8752253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is IVF-served two different ways-more cost-effective than IUI with controlled ovarian hyperstimulation?
    Tjon-Kon-Fat RI; Bensdorp AJ; Bossuyt PM; Koks C; Oosterhuis GJ; Hoek A; Hompes P; Broekmans FJ; Verhoeve HR; de Bruin JP; van Golde R; Repping S; Cohlen BJ; Lambers MD; van Bommel PF; Slappendel E; Perquin D; Smeenk J; Pelinck MJ; Gianotten J; Hoozemans DA; Maas JW; Groen H; Eijkemans MJ; van der Veen F; Mol BW; van Wely M
    Hum Reprod; 2015 Oct; 30(10):2331-9. PubMed ID: 26269539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-saving treatment strategies in in vitro fertilization: a combined economic evaluation of two large randomized clinical trials comparing highly purified human menopausal gonadotropin and recombinant follicle-stimulating hormone alpha.
    Wechowski J; Connolly M; Schneider D; McEwan P; Kennedy R
    Fertil Steril; 2009 Apr; 91(4):1067-76. PubMed ID: 18339384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified natural cycle versus controlled ovarian hyperstimulation IVF: a cost-effectiveness evaluation of three simulated treatment scenarios.
    Groen H; Tonch N; Simons AH; van der Veen F; Hoek A; Land JA
    Hum Reprod; 2013 Dec; 28(12):3236-46. PubMed ID: 24166594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How will changes in health insurance tax policy and employer health plan contributions affect access to health care and health care costs?
    Marquis MS; Buchanan JL
    JAMA; 1994 Mar 23-30; 271(12):939-44. PubMed ID: 8120964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Employer contribution and premium growth in health insurance.
    Liu Y; Jin GZ
    J Health Econ; 2015 Jan; 39():228-47. PubMed ID: 25241905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of expanded mental health benefits on treatment costs.
    Sasso AT; Lurie IZ; Lee JU; Lindrooth RC
    J Ment Health Policy Econ; 2006 Mar; 9(1):25-33. PubMed ID: 16733269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Employer drug benefit plans and spending on prescription drugs.
    Joyce GF; Escarce JJ; Solomon MD; Goldman DP
    JAMA; 2002 Oct; 288(14):1733-9. PubMed ID: 12365957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro fertilization availability and utilization in the United States: a study of demographic, social, and economic factors.
    Hammoud AO; Gibson M; Stanford J; White G; Carrell DT; Peterson M
    Fertil Steril; 2009 May; 91(5):1630-5. PubMed ID: 18539275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the cost-to-benefit ratio of in-vitro fertilization.
    Silva PD; Sorensen ML; Silva DE
    Wis Med J; 1997 Jan; 96(1):36-9. PubMed ID: 9020620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective evaluation of prognosis and cost-effectiveness of IVF in poor responders according to the Bologna criteria.
    Busnelli A; Papaleo E; Del Prato D; La Vecchia I; Iachini E; Paffoni A; Candiani M; Somigliana E
    Hum Reprod; 2015 Feb; 30(2):315-22. PubMed ID: 25432927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.